These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7937770)
21. Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay. Munck A; Kervran A; Marie JC; Bataille D; Rosselin G Peptides; 1984; 5(3):553-61. PubMed ID: 6473171 [TBL] [Abstract][Full Text] [Related]
22. Insulin and proglucagon-derived peptides from the horned frog, Ceratophrys ornata (Anura:Leptodactylidae). White AM; Secor SM; Conlon JM Gen Comp Endocrinol; 1999 Jul; 115(1):143-54. PubMed ID: 10375473 [TBL] [Abstract][Full Text] [Related]
23. Isolation of peptide hormones from the pancreas of the bullfrog (Rana catesbeiana). Amino acid sequences of pancreatic polypeptide, oxyntomodulin, and two glucagon-like peptides. Pollock HG; Hamilton JW; Rouse JB; Ebner KE; Rawitch AB J Biol Chem; 1988 Jul; 263(20):9746-51. PubMed ID: 3260236 [TBL] [Abstract][Full Text] [Related]
24. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat. Fothergill LJ; Ringuet MT; Sioras E; Hunne B; Fazio Coles TE; Martins PR; Furness JB Cell Tissue Res; 2019 Feb; 375(2):359-369. PubMed ID: 30259122 [TBL] [Abstract][Full Text] [Related]
25. Solid-phase peptide synthesis of human(Nle-27)-oxyntomodulin. Preliminary evaluation of its biological activities. Audousset-Puech MP; Dufour M; Kervran A; Jarrousse C; Castro B; Bataille D; Martinez J FEBS Lett; 1986 May; 200(1):181-5. PubMed ID: 3009226 [TBL] [Abstract][Full Text] [Related]
26. The primary structure of porcine glicentin (proglucagon). Thim L; Moody AJ Regul Pept; 1981 May; 2(2):139-50. PubMed ID: 6894800 [TBL] [Abstract][Full Text] [Related]
28. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro. Lui EY; Asa SL; Drucker DJ; Lee YC; Brubaker PL Endocrinology; 1990 Jan; 126(1):110-7. PubMed ID: 2152861 [TBL] [Abstract][Full Text] [Related]
29. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells. Rodier G; Magous R; Mochizuki T; Martinez J; Nguyen DL; Bali JP; Bataille D; Jarrousse C Pflugers Arch; 1997 Nov; 434(6):729-34. PubMed ID: 9306005 [TBL] [Abstract][Full Text] [Related]
30. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Fischer KD; Dhanvantari S; Drucker DJ; Brubaker PL Am J Physiol; 1997 Oct; 273(4):E815-20. PubMed ID: 9357813 [TBL] [Abstract][Full Text] [Related]
32. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene. Brubaker PL; Lee YC; Drucker DJ J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210 [TBL] [Abstract][Full Text] [Related]
33. Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. Ghatei MA; Goodlad RA; Taheri S; Mandir N; Brynes AE; Jordinson M; Bloom SR Dig Dis Sci; 2001 Jun; 46(6):1255-63. PubMed ID: 11414302 [TBL] [Abstract][Full Text] [Related]
34. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Dhanvantari S; Brubaker PL Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943 [TBL] [Abstract][Full Text] [Related]
35. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286 [TBL] [Abstract][Full Text] [Related]
36. H-Lys-Arg-Asn-Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin. Carles-Bonnet C; Martinez J; Jarrousse C; Aumelas A; Niel H; Bataille D Peptides; 1996; 17(3):557-61. PubMed ID: 8735987 [TBL] [Abstract][Full Text] [Related]
37. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217 [TBL] [Abstract][Full Text] [Related]
38. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas. Philippe J; Mojsov S; Drucker DJ; Habener JF Endocrinology; 1986 Dec; 119(6):2833-9. PubMed ID: 3536450 [TBL] [Abstract][Full Text] [Related]
39. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Moody AJ; Holst JJ; Thim L; Jensen SL Nature; 1981 Feb; 289(5797):514-6. PubMed ID: 7007887 [TBL] [Abstract][Full Text] [Related]
40. Role of prohormone convertases in the tissue-specific processing of proglucagon. Dhanvantari S; Seidah NG; Brubaker PL Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]